PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
12345678,Advances in Cancer Immunotherapy,2024-11-15,Dr. Alice Johnson,BioGenix Pharma Ltd.,alice.johnson@biogenix.com
23456789,Targeted Drug Delivery in Oncology,2025-02-20,Dr. Rajesh Kumar,TheraBioTech Inc.,rajesh.kumar@therabio.com
